Vertex Pharmaceuticals
VRTX
#175
Rank
ยฃ87.53 B
Marketcap
ยฃ341.41
Share price
-0.41%
Change (1 day)
-8.17%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ5.65 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ5.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ4.87 B20.72%
2023-12-31ยฃ4.04 B15.39%
2022-12-31ยฃ3.50 B41.9%
2021-12-31ยฃ2.46 B9.79%
2020-12-31ยฃ2.24 B32.03%
2019-12-31ยฃ1.70 B19.39%
2018-12-31ยฃ1.42 B28.21%
2017-12-31ยฃ1.11 B-11.92%
2016-12-31ยฃ1.26 B33.23%
2015-12-31ยฃ0.94 B19.18%
2014-12-31ยฃ0.79 B36.31%
2013-12-31ยฃ0.58 B-39.67%
2012-12-31ยฃ0.96 B17.84%
2011-12-31ยฃ0.82 B3.74%
2010-12-31ยฃ0.79 B49.03%
2009-12-31ยฃ0.53 B4.92%
2008-12-31ยฃ0.50 B204.45%
2007-12-31ยฃ0.16 B-21.68%
2006-12-31ยฃ0.21 B18.11%
2005-12-31ยฃ0.17 B-32.37%
2004-12-31ยฃ0.26 B-10.6%
2003-12-31ยฃ0.29 B9%
2002-12-31ยฃ0.27 B-12.11%
2001-12-31ยฃ0.31 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
ยฃ27.79 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ102.31 B 1,709.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ58.19 B 929.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ58.68 B 937.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.10 B 1,405.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
ยฃ0.16 B-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA